Reading Time: 9 minutesA paper arising from research carried out at the University of Sheffield as part of the AMBRoSIA biobank, and in collaboration with the international Project
Search Results for: clinical trial
Reading Time: 3 minutesA study conducted by researchers at the Euan MacDonald Centre at the University of Edinburgh has shed light on how improving the function of mitochondria
Reading Time: 4 minutesIt’s that time of year again. With just a week to go until the 31st International Symposium on ALS/MND, we thought we’d bring you an
Reading Time: 5 minutesCristina Cabassi is an honorary research assistant investigating fasciculations in people with MND. In this guest blog she tells us a little about herself and
Reading Time: 6 minutesIn July 2020 Everything ALS, a team of patient advocates, medical professionals, entrepreneurs, computational biologists and medical students based in the USA, hosted a virtual
Reading Time: 3 minutesA recently published paper, reviewing 15 studies that investigated the effectiveness of riluzole as a treatment for MND in real-time, has suggested that the drug
Reading Time: 4 minutesGuest researcher blog post: My name is Sophie Nyberg and I am a neuroscientist currently working in the Lighthouse COVID-19 testing labs in Alderley Park,
Reading Time: 5 minutesLast Thursday marked an exciting milestone in the search for effective therapies for MND as full results from the early-phase 1/2 trial of Biogen’s tofersen
Reading Time: 4 minutesAlthough ALS is a neurodegenerative disease, researchers are increasingly also interested in events happening outside the brain and spinal cord, in particular whether changes in
Reading Time: 2 minutesGuest researcher blog post written by Elisabeth Jirström: Hi! My name is Elisabeth Jirström and I am a PhD student at Royal College of Surgeons